The term injection includes administration of intravenous (IV), intramuscular (IM), and subcutaneous (SC) areas.
The benefit of injections as a drug delivery form is that they act swiftly. The onset of action for IV is 15–30 seconds, IM is 10–20 minutes and SC is 15–30 minutes. Injections are also essentially bioavailable. They are helpful for drugs that are inefficient in their absorbtion or worse, do not show any result through oral administration.
Certain drugs, especially antipsychotics, are best delivered through long-acting IM injections. In process IV injectables can be helpful for delivery of regular drugs, even in the form of liquids. In some cases, patients are trained to use the injectables themselves. Injections required in SC areas to give insulin is patient-friendly. They can be managed without the involvement of highly trained profesionals.
Foreseen to vouch for approx. 3.1 - 3.6% of the world’s pharmaceutical industry by value.
10% of the global industry by volume.
Revenue of Indian pharma industry will result in USD 45 Billion.
It will result in USD 45 Billion by the end of 2020.
By then, the Indian healthcare sector is expected to touch USD 250 Billion as a turnover from USD 65 Billion.
It is envisioned to increase to USD 26.1 Billion by 2016 from USD 11.3 Billion in 2011
High quality that meets International parameters
Exhaustive Research & Development backup
Competitive pricing that reflects our dynamic policy
Ability in meeting bulk orders as quickly as possible